The 100 Most Influential CEOs in Oncology in 2025 (Full List)
Gevorg Tamamyan: Just Get Things Done
Oncology This Week: OncoDaily Weekly Jan 5-11
Nigeria and the U.S. Forge New Health Partnership Following USAID Cuts
Cristian Rivera Foundation Makes the Largest Donation to Date: $365,000 Gift to Support DIPG Research at Weill Cornell Medicine
Top 10 OncoGrants of the Week: AACR Conference Support, Major Award Nominations, and Targeted Research Funding
Chadi Nabhan and Jasmine Kamboj: How ''Policy and Economics of Medicine'' is Pivotal
BGICC: The Precision Medicine Revolution
"Going Full TILt: challenges, successes, and coordination with administering TIL therapy" is an upcoming "Rx-cited: Clinical Conundrums" roundtable organized by the ASTCT Pharmacy SIG Research Subcommittee and New Practitioner Task […]
The 2026 ASCO Gastrointestinal Cancers Symposium will take place from January 8–10, 2026, at Moscone West in San Francisco, CA, as well as online. This annual event gathers oncology professionals […]
The Highlights of ASH in North America is a two-day program offered by the American Society of Hematology (ASH) in multiple locations to explore and discuss the most influential and […]
The ANCO’s Medicare Regulations Update 2026 webinar on January 14, 2026, will provide a comprehensive overview of the latest Medicare changes affecting oncology services. Bobbi Buell, MBA, will cover updates to the Physician Fee Schedule, coding and billing, evaluation and management, and incentive programs, offering essential insights for clinicians and practice teams. Register here.
The SEER-MHOS 2026 Update: Your Guide to the New Data Linkage is a specialized technical webinar hosted by the National Cancer Institute (NCI) Division of Cancer Control and Population Sciences. Scheduled for January 15, 2026, this session is designed for health services researchers, epidemiologists, and oncology professionals interested in leveraging large-scale data to study cancer […]
The MASCC Webinar “ADCs and Mucositis: From Mechanism to Care” on January 15, 2026, at 8:00 PM UTC+4 will explore the therapeutic potential and toxicity of antibody-drug conjugates (ADCs), with a focus on the recognition, prevention, and management of ADC-induced oral mucositis. Expert speakers, including Prof. Paolo Bossi, Prof. Florian Scotté, Dr. Barbara Pistilli, Dr. […]
The ESMO Preceptorship on Breast Cancer 2026: Milan is a two-day educational course that provides oncologists with a thorough understanding of breast cancer management, covering topics from diagnosis to treatment, based on current standards of care in a multidisciplinary setting. The preceptorship will take place from January 16–17, 2026, in Milan, Italy. The course is […]
The Cancer Immunotherapy Winter School, hosted by the Society for Immunotherapy of Cancer (SITC), is a hybrid program taking place in Boston and virtually from February 16–18, 2026, with the in-person meeting held at The Westin Copley Place, Boston. The school is tailored for early-to-mid career scientists and clinicians who are new to the field, […]
The 22nd Oncology Updates: Advanced and Controversies Conference, presented by The University of Texas MD Anderson Cancer Center, is an interactive, multidisciplinary forum held from Friday, January 16 to Monday, January 19, 2026, at the Steamboat Grand Hotel in Steamboat Springs, Colorado. The conference is designed to address the rapidly evolving complexities of solid tumor […]
The 2nd Annual Cleveland Clinic Cancer Conference: Innovations in Multidisciplinary Care will be held from January 16 to 18, 2026, in Hollywood, Florida. This premier event brings together a diverse range of oncology professionals including medical oncologists, hematologists, radiation oncologists, and other healthcare providers to explore the latest developments in cancer diagnosis, treatment, and supportive […]
The UK Interdisciplinary Breast Cancer Symposium (UKIBCS) 2026 is a biennial scientific meeting scheduled for January 19–20, 2026, at the International Convention Centre (ICC) in Birmingham, United Kingdom. Organized through a collaboration between Breast Cancer Now, the British Oncology Pharmacy Association (BOPA), the Association of Breast Surgery (ABS), and KC Jones Conference and Events, the […]
The European Association for Cancer Research (EACR) conference, "Overactivation of Oncogenic Signalling as a Potential Cancer Treatment Strategy," is a Virtual Event scheduled for January 20-21, 2026. This conference explores a paradoxical and radically different approach to cancer therapy: instead of inhibiting the signals that drive cancer, it focuses on the deliberate hyper-activation of oncogenic […]
